We are monitoring the impact of COVID-19 on North America Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 898
Share on
Share on

North America Hormone Replacement Therapy Market Research Report - Segmented By Hormone Type, By Route Of Administration & By Country (U.S, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 898
Pages: 133

North America Hormone Replacement Therapy Market Size & Growth (2021 to 2026):

As per the research report, the size of the North America Hormone Replacement Therapy Market Size is valued at USD 7.25 billion in 2021 and is predicted to reach USD 10.23 billion by 2026, growing at a CAGR of 7.12% during the forecast period 2021 to 2026.

Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed.

Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs that require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of North America hormone replacement therapy market.

However, based on research studies, hormone replacement therapy can cause severe side effects, such as bleeding, breast tenderness or enlargement, bloating, mood changes, headaches, and nausea, risk of breast cancer, heart disease, and stroke. Along with this, the high cost of therapy is limiting its reach to middle-class people.  Further, women with high susceptibility to coronary diseases are advised to stay away from hormone replacement therapy thereby decreasing the size of the target audience.

This research report segmented and sub-segmented into the following categories:

  • By Hormone Type: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy, and others.
  • By Route of Administration: Oral, transdermal, parenteral, and other routes.
  • By Country: U.S, Canada and Rest of North America

The USA dominates the market in the region owing to the economic conditions, awareness among women and government reimbursement policies present. Most of the time, therapies are carried out through oral routes, followed by parenteral administrations.

Companies playing a dominant role in the North America Hormone Replacement Therapy Market profiled in this report are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co, Amgen, Eli Lily, Bayer, Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc

1.Introduction         

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions  

2. Research Methodology                  

                2.1 Introduction     

                2.2 Research Phases        

                                2.2.1 Secondary Research                                            

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                     

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview             

                3.1 Executive Summary  

                3.2 Key Inferences

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers 

                4.2 Market Restraints      

                4.3 Key Challenges

                4.4 Current Opportunities in the Market 

5. Market Segmentation                     

                 5.1 By Hormone Type     

                                5.1.1 Estrogen Replacement Therapy                                     

                                5.1.2 Growth Hormone Replacement Therapy                                   

                                5.1.3 Thyroid Replacement Therapy                                       

                                5.1.4 Others                                      

                5.2 By Route of Administration   

                                5.2.1 Oral                                            

                                5.2.2 Parenteral                               

                                5.2.3 Transdermal                                           

                                5.2.4 Others                                      

6. Geographical Analysis                     

                                6.1 Introduction

                                6.2 United States                                            

                                6.3 Canada                                         

7. Pipeline Product Analysis              

                7.1 Overview           

                7.2 Pipeline Development Landscape           

                7.3 Molecular Targets in the Pipeline            

                7.4 Clinical Trials    

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target    

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target. 

8.Strategic Analysis               

                8.1 PESTLE analysis

                                8.1.1 Political                                     

                                8.1.2 Economic                                 

                                8.1.3 Social                                         

                                8.1.4 Technological                                         

                                8.1.5 Legal                                          

                                8.1.6 Environmental                                      

                8.2 Porter’s Five analysis     

                                8.2.1 Bargaining Power of Suppliers                                        

                                8.2.2 Bargaining Power of Consumers                                    

                                8.2.3 Threat of New Entrants                                     

                                8.2.4 Threat of Substitute Products and Services                               

                                8.2.5 Competitive Rivalry within the Industry                                      

9.Market Leaders' Analysis                 

                9.1 Abbott Laboratories 

                                9.1.1 Overview                                

                                9.1.2 Product Analysis                                   

                                9.1.3 Financial analysis                                  

                                9.1.4 Recent Developments                                       

                                9.1.5 SWOT analysis                                       

                                9.1.6 Analyst View                                          

                9.2 Novartis         

                9.3 Pfizer   

                9.4 Mylan Laboratories   

                9.5 Amgen

                9.6 Merck & Co. 

                9.7 Bayer   

                9.8 Eli Lily & Company    

                9.9 Novo Nordisk   

                9.10 Wyeth          

                9.11 F. Hoffmann-La Roche

                9.12 Hisamitsu Pharmaceutical  Co. Inc.   

10.Competitive Landscape                 

                10.1 Market share analysis 

                10.2 Merger and Acquisition Analysis       

                10.3 Agreements, collaborations and Joint Ventures         

                10.4 New Product Launches         

11.Expert Opinions                

                11.1 Market Outlook       

                11.2 Investment Opportunities   

Appendix                  

                a) List of Tables  

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  2. North America Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  3. North America Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  4. North America Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  5. North America Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  6. North America Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  7. North America Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  8. United States Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  9. United States Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  10. Canada Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  11. Canada Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample